Health
Altering balance of fibroblasts could prevent spread of colorectal cancer – Drug Target Review
Researchers found colorectal cancer-associated fibroblasts can be altered with a gremlin 1-neutralising antibody or overexpressing meflin.
Posted: 1 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found that colorectal cancer-associated fibroblasts can be altered using a gremlin 1-neutralising antibody or by overexpressing meflin.
Researchers have revealed that colorectal cancer tissues contain at least two types of fibroblasts – cancer-promoting fibroblasts and cancer-restraining fibroblasts. The team, from Nagoya University, Japan, found that the balance between the two is largely involved in…
-
General22 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News24 hours agoSunshine Coast women celebrated at 26th annual business awards
-
Noosa News17 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News21 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station